(Total Views: 997)
Posted On: 01/19/2022 8:24:59 AM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
CD16 and 17 phase 3 trials are firmly established with a legitimate CRO, dozens of trial sites (23 in critical and 27 in severe) and now the much-needed flood of patients in Brazil. Furthermore, efficacy in severe and critical Covid will be compelling for an EUA/approval.
Waiting on LH, for which a phase 3 trial has not even been approved will put us into 2023.
Brazilian trials are are our quickest route to EUA/approval.
Waiting on LH, for which a phase 3 trial has not even been approved will put us into 2023.
Brazilian trials are are our quickest route to EUA/approval.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)